findmyKOL
Clinical trialNCT04692376UnknownPhase 2Interventional

MSC for Treatment of cGVHD After Allo-HSCT

SponsorNanfang Hospital, Southern Medical UniversityEnrollment152Chronic Graft-versus-host Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the efficacy of mesenchymal stem cells in patients with chronic graft-versus-host disease.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Department of Hematology,nanfang Hospital, Southern Medical University

    Guangzhou, Guangdong, China

    Qifa Liu
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

GlucocorticoidsMesenchymal stem cellsCyclosporine →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
10 Jan 2021
Primary completion
31 Dec 2022
Completion
30 Jun 2023
Last update posted
31 Dec 2020
Registered enrollment
152
Registry id
NCT04692376
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.